No results for ‘’
ERIS Lifesciences Ltd
₹1355.50
(0.08%)
Mon, 21 Sept 2026, 09:56 pm
Health Technology
Pharmaceuticals: Major
24.5KERIS Lifesciences Share Price Live Chart
1 Day
(0.08%)
No Result Found
Summary
Market Cap (in Cr)
19373.78
Net Profit (in Cr)
374.67
P/B
6.76
Sector P/E
33.76
P/E
54.84
EV/EBITDA
20.81
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
13.77
ROCE
13.29
Debt/Equity
0.97
EPS (TTM)
45.65
Dividend Yield
0.52
Book Value
281.64
Interest Cover
3.11
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 53.92 | 54.85 | 54.85 | 54.84 | 54.85 |
| FII | 6.39 | 6.85 | 7.21 | 8.40 | 8.43 |
| DII | 20.35 | 20.32 | 19.36 | 18.17 | 18.07 |
| Public | 19.33 | 17.99 | 18.57 | 18.59 | 18.66 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1569.07 | 1451.07 | 1374.13 | 1333.07 | 1256.13 | 1215.07 | 1097.07 |
| Fibonacci | 1451.07 | 1405.99 | 1378.14 | 1333.07 | 1287.99 | 1260.14 | 1215.07 |
| Camarilla | 1329.65 | 1318.83 | 1308.02 | 1333.07 | 1286.38 | 1275.57 | 1264.75 |
Pivots Level: Classic
R3
+236
1569.07
R2
+118
1451.07
R1
+41.07
1374.13
S1
-76.93
1256.13
S2
-118
1215.07
S3
-236
1097.07
Moving Average
Period
Value
10-EMA
1316.50
20-EMA
1324.15
30-EMA
1333.78
50-EMA
1349.46
100-EMA
1372.37
200-EMA
1405.73
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 20 May 2026 | dividend | ₹7.21 Dividend /Share | 29 May 2026 |
| 20 May 2026 | board-meetings | Accounts, Quarterly Results, Interim Dividend | |
| 13 Feb 2026 | board-meetings | Quarterly Results | |
| 30 Jun 2025 | agm | ||
| 07 Feb 2025 | dividend | ₹7.35 Dividend /Share | 13 Feb 2025 |
| 13 Jan 2025 | dividend | Interim Dividend - Rs. - 7.35 | 13 Feb 2025 |
| 04 Sept 2024 | agm | ||
| 17 Aug 2024 | agm | Annual General Meeting | 18 Sept 2024 |
| 15 Aug 2023 | agm | Annual General Meeting | 18 Sept 2023 |
| 07 Aug 2023 | agm |
Peer Comparison
ERIS Lifesciences Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
ERIS Lifesciences Ltd About
ERIS Lifesciences manufactures, markets, and sells generic drugs. The Company provides a wide range of products in chronic and acute therapy segments which includes capsules, tablets, and sachets. Eris Lifesciences also focuses on hypertension, anti-diabetes, metabolic disorders, lipid lowering, and therapeutic areas. Eris Lifesciences serves the pharmaceutical markets in India.
Industry
Pharmaceuticals - Indian - Formulations
Founded
2007
Headquarters
CEO
Amit Indubhushan Bakshi
Employees
Contact
Website
http://www.eris.co.in
complianceofficer@erislifesciences.com
Phone
91-79-30451000
Location
8th Floor Commerce House -IV, Prahladnagar 100 FT Road, Ahmedabad, Gujarat, 380015
ERIS Lifesciences Ltd Company History
| Year | History |
|---|---|
| 2016 |
|
| 2017 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| MOTILAL OSWAL FINANCIAL SERVICES LIMITED | bulk | Buy | 2079000 | 1350.18 | 03 Oct 2024 |
| RAKESH SHAH | bulk | Sell | 2000000 | 1350 | 03 Oct 2024 |
| EMERALD INVESTMENTS LIMITED | bulk | Sell | 9886882 | 1201 | 22 Aug 2024 |
| EMERALD INVESTMENTS LIMITED | block | Sell | 9886882 | 1201 | 22 Aug 2024 |
| INFINITY PARTNERS | bulk | Buy | 9886882 | 1201 | 22 Aug 2024 |
| INFINITY PARTNERS | block | Buy | 9886882 | 1201 | 22 Aug 2024 |
| FRANKLIN TEMPLETON MUTUAL FUND | bulk | Buy | 1094201 | 1000.04 | 15 Jul 2024 |
| RAKESH SHAH | bulk | Sell | 2000000 | 1000.12 | 15 Jul 2024 |
| BHIKHALAL CHIMANLAL SHAH | bulk | Sell | 1280000 | 913.09 | 31 Jan 2024 |
| BHIKHALAL CHIMANLAL SHAH | bulk | Sell | 820000 | 912.5 | 31 Jan 2024 |
Frequently Asked Questions
1.What is the stock price of ERIS Lifesciences Ltd?
As of 22/09/2026 at 3:26 AM, ERIS Lifesciences Ltd shares are trading at ₹1355.50.
2.What is the market cap. of ERIS Lifesciences Ltd?
As of 22/09/2026, the market capitalization of ERIS Lifesciences Ltd is ₹18,805.76 crore.
3.When was ERIS Lifesciences Ltd founded?
ERIS Lifesciences Ltd was founded in 2007.
4.What are the P/E and P/B ratios of ERIS Lifesciences Ltd?
As of 22/09/2026, ERIS Lifesciences Ltd has a P/E ratio of 28.86 and a P/B ratio of 6.76.
5.How can I buy shares of ERIS Lifesciences Ltd?
You can buy shares of ERIS Lifesciences Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of ERIS Lifesciences Ltd?
As of March,2026, promoters hold 53.92% in ERIS Lifesciences Ltd, while FIIs, DIIs and public shareholders hold 6.39%, 20.35% and 19.33%, respectively.
7.Does ERIS Lifesciences Ltd pay dividends?
Yes, ERIS Lifesciences Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹7.21 Dividend /Share per share.
8.What is the dividend yield of ERIS Lifesciences Ltd?
As of 22 September, 2026, the dividend yield of ERIS Lifesciences Ltd stands at 0.53%.
9.What are the latest financial results of ERIS Lifesciences Ltd?
For January,2024, ERIS Lifesciences Ltd reported revenue of ₹2,894.00 crore and a net profit of ₹352.00 crore.
10.What is the Stock symbol of ERIS Lifesciences Ltd?
ERIS is the stock symbol of ERIS Lifesciences Ltd.
11.Who is the CEO of ERIS Lifesciences Ltd?
The CEO of ERIS Lifesciences Ltd is Amit Indubhushan Bakshi.